Related Experiment Video
Updated: Mar 13, 2026
10:54
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
710
Agomelatine for Depression in Schizophrenia: A Case-Series
Jochen Mutschler1, Nicolas Rüsch1, Herdis Schönfelder1
1Drs. Mutschler, MD, Rüsch, MD, Schönfelder, MD, Herwig, MD, Brühl, MD, Rössler, MD, Russmann, MD, Department of General and Social Psychiatry, Psychiatric University Hospital Zürich, Militärstrasse 8, Zürich, Switzerland. Dr. Grosshans, MD, Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Mannheim J5, Germany.
Psychopharmacology Bulletin
|October 15, 2016
Summary
Agomelatine effectively treated depressive and negative symptoms in patients with schizophrenia. This new antidepressant was well-tolerated, showing promise for managing complex psychiatric conditions.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Schizophrenia often presents with comorbid major depressive episodes and negative symptoms.
- Agomelatine, a novel antidepressant, targets melatonin (MT1/MT2) and serotonin (5-HT2C) receptors.
Purpose of the Study:
- To investigate the efficacy and safety of agomelatine in treating depressive and negative symptoms in schizophrenia patients.
- To assess the tolerability of agomelatine as an adjunctive therapy.
Main Methods:
- A case series of seven schizophrenia patients with comorbid depressive symptoms treated with agomelatine for at least six weeks.
- Assessment of general psychopathology, positive, negative, and depressive symptoms using standardized interviews.
- Monitoring of relevant blood parameters.
Main Results:
- Significant improvement in depressive symptoms observed.
- Significant reduction in negative symptoms and global psychopathology.
- Agomelatine demonstrated good tolerability in the majority of patients.
Conclusions:
- Agomelatine shows initial promise as a safe and effective treatment for depressive symptoms in schizophrenia.
- Evidence suggests agomelatine may also be beneficial for negative symptoms in this population.
- Further confirmation through randomized controlled trials is warranted.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:25Antidepressant Drugs: Overview
1.9K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.9K
01:27Depressive Disorders: MDD and Dysthymia
999
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
999
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.9K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.9K
01:18Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
01:26Psychosis: Goals of Pharmacotherapy
649
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
649